Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 718 (USA) (Dr. Nolan)
· consented 2013-02-17
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-14 (study day 57.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-04-14 (study day 57.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-06 (study day 140.0); relationship: NONE
mild
assessed
2026-08-18
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-13 (study day 56.0); relationship: NONE
mild
assessed
2026-08-18
Mild SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 56.0); relationship: NONE
mild
assessed
2026-08-18
Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-03-06 (study day 18.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.